Dr. Bridge-Cook is a highly accomplished In Vitro Diagnostics (IVD) executive with comprehensive experience developing and launching innovative IVD products onto global markets. Prior to assuming the President and CEO role at Rna Diagnostics, Dr. Bridge-Cook was engaged for 16 years in progressively senior business development, research and development and general management roles at Tm Bioscience (TMB) and Luminex Corporation, which acquired TMB in 2007. Dr. Bridge-Cook was a corporate officer and Senior Vice President of R&D at Luminex, a NASDAQ listed corporation that develops, manufacturers and markets IVD and biological testing technologies for the clinical diagnostic and life science industries. Dr. Bridge-Cook was instrumental in delivering new molecular diagnostic systems and assays from inception to successful commercial launch. Dr. Bridge-Cook obtained a B.Sc., Biology from McMaster University and a Ph.D., Immunology from University of Toronto.